President Trump said that prescription benefit managers, or PBMs, would be left out of a new government initiative aimed at ...

Iowa, suggested Congress could once again move to overhaul PBMs’ controversial business practices after legislators pass ...

Shares of Septerna SEPN surged 51% on May 14 after the company entered into an exclusive global collaboration and license ...

Illinois and CVS Caremark reach a $45 million settlement over pharmaceutical rebates, lowering the liability to taxpayers for ...

While M&A activity has slowed in the tail end of the first quarter of 2025, including in healthcare, there have been several noteworthy ...

Sen. Josh Hawley, R-Mo., demanded Tuesday that Congress move to stop insurance companies from owning pharmacy benefit ...

President Donald Trump's new health care initiative aims to reduce prescription drug costs by targeting pharmacy benefit managers, commonly known as PBMs.

Despite its expensive valuation and declining estimates, we suggest investors hold LLY stock as the company boasts solid ...

In 2023, the Blue Shield of California announced that it was dropping CVS Caremark as its pharmacy benefit manager (PBM) and ...

Even if the order takes effect, it will do nothing to address the root causes of the problem it purports to solve.

CVS Health Corporation CVS and The Cigna Group CI shares trading lower Tuesday. President Donald Trump on Monday signed an ...

The Most Favored Nation directive would allow drugmakers to directly sell their products to patients at a lower cost, cutting ...